AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ANTX…

AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

AN2 Therapeutics, Inc.

ANTX · CIK 1880438

4 · Sep 16, 2026 · Chief Medical Officer Trenor Cameron C. III was granted 350K shares

4

Chief Medical Officer Trenor Cameron C. III was granted 350K shares

Filed: Sep 16, 2026
Period: Sep 15, 2026
Accession: 0001193125-26-393274
Filer: AN2 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov